MagForce AG

MF6 · STU · Healthcare / Medical Devices

0.0025EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.0025

Open0.0025

Day Range0.0025 – 0.003

52-Week Range0.001 – 0.014

Volume250

Market Cap59.86K

P/E (TTM)0.00

Forward P/E0.00

EPS-0.35

Dividend Yield0.00%

Beta-6.33

50-Day Avg0.003

200-Day Avg0.0036

About

MagForce AG develops advanced nanomedicine for cancer therapies. It offers NanoTherm therapy system, a combination of medical devices for the treatment of solid brain tumors; NanoPlan, a software that stimulates the temperature distribution in the treatment area; NanoTherm, a magnetic ferrofluid; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.

Company Details

SectorHealthcare
IndustryMedical Devices
CEODr. Benjamin J. Lipps
Employees33
HeadquartersMax-Planck-Straße 3, Berlin, Germany, 12489, Germany
Websitehttps://www.magforce.de/

Leadership

Dr. Benjamin J. LippsChairman of the Management Board & CEO · b. 1940
Dr. Andreas JordanExecutive VP, Chief Scientific Officer & MD of Europe · b. 1959
Ms. Barbara Von FrankenbergVice President of Communications & Investor Relations
Ms. Solveig SalomonVP of Marketing & Sales and European Commercial Director

Financials

Income Statement

Currency: EUR	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Total Revenue	67.20K	839.93K	621.14K	351.98K
Growth (%)	-	+1149.90%	-26.05%	-43.33%
Cost of Revenue	455.35K	-53.64K	186.49K	668.59K
Gross Profit	-388.15K	893.57K	434.65K	-316.61K
Gross Margin	-577.60%	106.39%	69.98%	-89.95%
Operating Expense	-7.28M	6.65M	-18.94M	5.69M
Operating Income	6.90M	-5.76M	19.37M	-6.01M
Operating Margin	10262.05%	-685.74%	3118.46%	-1707.62%
EBITDA	6.78M	-6.40M	18.45M	-6.95M
EBITDA Margin	10089.93%	-762.41%	2970.73%	-1975.49%
Net Income	4.36M	-8.73M	14.75M	-10.57M
Net Income Margin	6485.20%	-1039.44%	2374.12%	-3004.19%
Interest Expense	1.82M	1.68M	3.04M	2.94M
Interest Expense % of Total Revenue	2712.53%	200.37%	489.06%	835.45%

Balance Sheet

Currency: EUR	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Total Assets	37.13M	36.66M	65.59M	62.83M
Total Liabilities	18.98M	21.95M	30.08M	35.99M
Total Equity	18.16M	14.71M	35.51M	26.84M
Cash	1.49M	167.42K	1.71M	114.74K
Net Debt	14.38M	16.51M	21.12M	25.53M

Cash Flow

Currency: EUR	2018-12-31	2019-12-31	2020-12-31	2021-12-31
Capital Expenditure	0	0	0	0

Key Statistics & Ratios

Market Cap59.86K

Enterprise Value25.54M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.06

Price / Book0.00

EPS-0.35

Book Value0.897

Revenue (TTM)1.08M

Gross Profit (TTM)158.39K

EBITDA-5.77M

Profit Margin0.00%

Operating Margin-462.93%

Return on Equity-33.92%

Return on Assets-6.27%

Shares Outstanding29.93M

Shares Float0

Beta-6.33

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%